<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Am J Case Rep</journal-id>
      <journal-id journal-id-type="iso-abbrev">Am J Case Rep</journal-id>
      <journal-id journal-id-type="publisher-id">amjcaserep</journal-id>
      <journal-title-group>
        <journal-title>The American Journal of Case Reports</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1941-5923</issn>
      <publisher>
        <publisher-name>International Scientific Literature, Inc.</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26572938</article-id>
      <article-id pub-id-type="pmc">4654591</article-id>
      <article-id pub-id-type="doi">10.12659/AJCR.895164</article-id>
      <article-id pub-id-type="publisher-id">895164</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Gastrointestinal Bleeding Secondary to Calciphylaxis</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Gupta</surname>
            <given-names>Nancy</given-names>
          </name>
          <xref ref-type="author-notes" rid="fn1-amjcaserep-16-818">
            <sup>A</sup>
          </xref>
          <xref ref-type="author-notes" rid="fn5-amjcaserep-16-818">
            <sup>E</sup>
          </xref>
          <xref ref-type="author-notes" rid="fn6-amjcaserep-16-818">
            <sup>F</sup>
          </xref>
          <xref ref-type="aff" rid="af1-amjcaserep-16-818">
            <sup>1</sup>
          </xref>
          <xref rid="c1-amjcaserep-16-818" ref-type="corresp"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Haq</surname>
            <given-names>Khwaja F.</given-names>
          </name>
          <xref ref-type="author-notes" rid="fn5-amjcaserep-16-818">
            <sup>E</sup>
          </xref>
          <xref ref-type="aff" rid="af1-amjcaserep-16-818">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mahajan</surname>
            <given-names>Sugandhi</given-names>
          </name>
          <xref ref-type="author-notes" rid="fn5-amjcaserep-16-818">
            <sup>E</sup>
          </xref>
          <xref ref-type="aff" rid="af2-amjcaserep-16-818">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nagpal</surname>
            <given-names>Prashant</given-names>
          </name>
          <xref ref-type="author-notes" rid="fn5-amjcaserep-16-818">
            <sup>E</sup>
          </xref>
          <xref ref-type="aff" rid="af3-amjcaserep-16-818">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Doshi</surname>
            <given-names>Bijal</given-names>
          </name>
          <xref ref-type="author-notes" rid="fn5-amjcaserep-16-818">
            <sup>E</sup>
          </xref>
          <xref ref-type="aff" rid="af1-amjcaserep-16-818">
            <sup>1</sup>
          </xref>
        </contrib>
      </contrib-group>
      <aff id="af1-amjcaserep-16-818"><label>1</label> Department of Medicine, Westchester Medical Center, New York Medical College, Valhalla, NY, U.S.A.</aff>
      <aff id="af2-amjcaserep-16-818"><label>2</label> Government Medical College, Amritsar, India</aff>
      <aff id="af3-amjcaserep-16-818"><label>3</label> Department of Radiology, University of Iowa Hospital and Clinics, Iowa City, IA, U.S.A.</aff>
      <author-notes>
        <fn>
          <p>Authors&#x2019; Contribution:</p>
        </fn>
        <fn id="fn1-amjcaserep-16-818">
          <label>A</label>
          <p>Study Design</p>
        </fn>
        <fn id="fn2-amjcaserep-16-818">
          <label>B</label>
          <p>Data Collection</p>
        </fn>
        <fn id="fn3-amjcaserep-16-818">
          <label>C</label>
          <p>Statistical Analysis</p>
        </fn>
        <fn id="fn4-amjcaserep-16-818">
          <label>D</label>
          <p>Data Interpretation</p>
        </fn>
        <fn id="fn5-amjcaserep-16-818">
          <label>E</label>
          <p>Manuscript Preparation</p>
        </fn>
        <fn id="fn6-amjcaserep-16-818">
          <label>F</label>
          <p>Literature Search</p>
        </fn>
        <fn id="fn7-amjcaserep-16-818">
          <label>G</label>
          <p>Funds Collection</p>
        </fn>
        <fn id="fn8-amjcaserep-16-818">
          <p><bold>Conflict of interest:</bold> None declared</p>
        </fn>
        <corresp id="c1-amjcaserep-16-818">Corresponding Author: Nancy Gupta, e-mail: <email>drnancygupta87@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>17</day>
        <month>11</month>
        <year>2015</year>
      </pub-date>
      <volume>16</volume>
      <fpage>818</fpage>
      <lpage>822</lpage>
      <history>
        <date date-type="received">
          <day>28</day>
          <month>6</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>30</day>
          <month>7</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Am J Case Rep, 2015</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license>
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License</license-p>
        </license>
      </permissions>
      <abstract>
        <p>
          <bold>Patient: Female, 66</bold>
        </p>
        <p>
          <bold>Final Diagnosis: Calciphylaxis</bold>
        </p>
        <p>
          <bold>Symptoms: Gastrointesinal haemorrhage</bold>
        </p>
        <p>
          <bold>Medication: None</bold>
        </p>
        <p>
          <bold>Clinical Procedure: Hemodialysis &#x2022; blood transfusions</bold>
        </p>
        <p>
          <bold>Specialty: Gastroenterology and Hepatology</bold>
        </p>
        <sec>
          <title>Objective:</title>
          <p>
            <bold>Rare disease</bold>
          </p>
        </sec>
        <sec>
          <title>Background:</title>
          <p>Calciphylaxis is associated with a high mortality that approaches 80%. The diagnosis is usually made when obvious skin lesions (painful violaceous mottling of the skin) are present. However, visceral involvement is rare. We present a case of calciphylaxis leading to lower gastrointestinal (GI) bleeding and rectal ulceration of the GI mucosa.</p>
        </sec>
        <sec>
          <title>Case Report:</title>
          <p>A 66-year-old woman with past medical history of diabetes mellitus, hypertension, end-stage renal disease (ESRD), recently diagnosed ovarian cancer, and on hemodialysis (HD) presented with painful black necrotic eschar on both legs. The radiograph of the legs demonstrated extensive calcification of the lower extremity arteries. The hospital course was complicated with lower GI bleeding. A CT scan of the abdomen revealed severe circumferential calcification of the abdominal aorta, celiac artery, and superior and inferior mesenteric arteries and their branches. Colonoscopy revealed severe rectal necrosis. She was deemed to be a poor surgical candidate due to comorbidities and presence of extensive vascular calcifications. Recurrent episodes of profuse GI bleeding were managed conservatively with blood transfusion as needed.</p>
          <p>Following her diagnosis of calciphylaxis, supplementation with vitamin D and calcium containing phosphate binders was stopped. She was started on daily hemodialysis with low calcium dialysate bath as well as intravenous sodium thiosulphate. The clinical condition of the patient deteriorated. The patient died secondary to multiorgan failure.</p>
        </sec>
        <sec>
          <title>Conclusions:</title>
          <p>Calciphylaxis leading to intestinal ischemia/perforation should be considered in the differential diagnosis in ESRD on HD presenting with abdominal pain or GI bleeding.</p>
        </sec>
      </abstract>
      <kwd-group>
        <title>MeSH Keywords</title>
        <kwd>Calciphylaxis</kwd>
        <kwd>Gastrointestinal Diseases</kwd>
        <kwd>Vascular Calcification</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Calciphylaxis was first described in 1961 in rat models by Selye [<xref rid="b1-amjcaserep-16-818" ref-type="bibr">1</xref>]. The first human example of calciphylaxis was described in 1968 [<xref rid="b2-amjcaserep-16-818" ref-type="bibr">2</xref>]. It is characterized by calcification of the intima media of the small arteries and arterioles with subsequent small vessel thrombosis, endovascular fibrosis, and downstream tissue ischemia [<xref rid="b2-amjcaserep-16-818" ref-type="bibr">2</xref>,<xref rid="b3-amjcaserep-16-818" ref-type="bibr">3</xref>].</p>
      <p>The most common presentation is the painful violaceous mottling of the skin, resembling livedo reticularis [<xref rid="b2-amjcaserep-16-818" ref-type="bibr">2</xref>,<xref rid="b4-amjcaserep-16-818" ref-type="bibr">4</xref>]. However, calciphylaxis rarely manifests with gastrointestinal complications [<xref rid="b5-amjcaserep-16-818" ref-type="bibr">5</xref>]. We present a case of calciphylaxis leading to rare visceral complications: intestinal ischemia, lower gastrointestinal bleeding, and ulceration of the gastro-intestinal mucosa.</p>
    </sec>
    <sec>
      <title>Case Report</title>
      <p>A 66-year-old woman with past medical history of diabetes mellitus, hypertension, end-stage renal disease on hemodialysis (via tunneled catheter), and recently diagnosed ovarian cancer presented to our hospital with complaints of painful rash on bilateral lower extremities. Her respiratory, cardiovascular, abdominal, and neurological exam results were un-remarkable. Skin examination demonstrated black necrotic eschar on bilateral lower extremities (<xref ref-type="fig" rid="f1-amjcaserep-16-818">Figure 1A, 1B</xref>). The radiograph of the legs demonstrated extensive calcification of the lower-extremity arteries (<xref ref-type="fig" rid="f1-amjcaserep-16-818">Figure 1C, 1D</xref>).</p>
      <p>A skin biopsy was not performed because of the clinically evident disease consistent with calciphylaxis. Our patient was particularly unusual because she had elevated parathyroid hormone (166 pg/ml), low calcium (7.9 mg/dl), normal phosphorus (2.6 mg/dl), and low calcium and phosphorus product. The highest calcium level in our hospital while the patient was on HD was 8.6 mg/dl (reference, 8.6&#x2013;10.2 mg/dl) and the highest phosphate level was 5.2 mg/dl (reference, 2.3&#x2013;4.7 mg/dl). The level of 25-hydroxy vitamin D was 8.6 ng/ml. We hemodialyzed her 5&#x2013;6 times a week for 4 hours per day. We were not able to give her cinacalcet because she had low calcium and low phosphate due to poor oral intake. Supplementation with vitamin D and calcium containing phosphate binders was stopped.</p>
      <p>The hospital course was complicated with an episode of lower gastrointestinal (GI) bleed leading to a drop in hemoglobin to 6.3 g/dl. Following the lower GI bleed, she underwent a CT scan of the abdomen/pelvis, which demonstrated severe circumferential calcification of the abdominal aorta and all its branches &#x2013; celiac artery, superior and inferior mesenteric arteries and their branches &#x2013; and extensive pneumoperitoneum with no evidence of extravasation of the contrast (<xref ref-type="fig" rid="f2-amjcaserep-16-818">Figure 2A, 2B</xref>). She also underwent colonoscopy, which revealed severe rectal ulceration extending up to the muscularis mucosa with rectal necrosis (<xref ref-type="fig" rid="f3-amjcaserep-16-818">Figure 3</xref>). The procedure was terminated because of the risk of perforation. No histologic specimens could be obtained.</p>
      <p>We considered colonic resection for the rectal ulceration; however, she was deemed to be a poor candidate for surgery due to comorbidities and presence of extensive vascular calcifications, which would have resulted in poor wound healing. The patient continued to have recurrent episodes of GI bleeding. We continued to manage her conservatively with repeated blood transfusions whenever the hemoglobin dropped below 7 g/dl.</p>
      <p>The patient was on broad-spectrum antibiotics (levofloxacin, metronidazole, cefepime, piperacillin-tazobactam, and vancomycin) and antifungals (fluconazole and later micafungin) due to the extensive skin lesions. Hyperbaric oxygen therapy was given. We attempted intravenous sodium thiosulfate along with hemodialysis, as a management strategy for calciphylaxis. There have been recent case reports of intradermal sodium thiosulfate injections that led to improvement of the skin lesions [<xref rid="b6-amjcaserep-16-818" ref-type="bibr">6</xref>]. We combined lidocaine with sodium thiosulphate and injected them intradermally around the areas that were violaceous, after obtaining consent from the patient and the health care proxy. Although it improved the pain, which could have been due to the lidocaine component of the injection, it led to worsening of the skin lesions, leading to abscess formation at the site of the injection.</p>
      <p>Clinical condition of the patient deteriorated and the patient subsequently died secondary to multiorgan failure, likely secondary to calciphylaxis and cardiopulmonary arrest.</p>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>Calciphylaxis is a rare disease, also known as metastatic calcification [<xref rid="b7-amjcaserep-16-818" ref-type="bibr">7</xref>]. Cutaneous purpura and necrosis are the cardinal features of calciphylaxis [<xref rid="b8-amjcaserep-16-818" ref-type="bibr">8</xref>]. Hence, dermatologists can play a key role in making an early diagnosis. There has been a case report where a patient with calciphylaxis presented with herpes simplex viral lesions [<xref rid="b9-amjcaserep-16-818" ref-type="bibr">9</xref>]. Thus, presence of concomitant conditions incidentally is unfortunate and can lead to missing the correct diagnosis of calciphylaxis [<xref rid="b9-amjcaserep-16-818" ref-type="bibr">9</xref>]. In such cases, the actual diagnosis is often not made until skin biopsy is performed. Biopsy reveals extensive deposits of calcium within the walls of blood vessels [<xref rid="b9-amjcaserep-16-818" ref-type="bibr">9</xref>,<xref rid="b10-amjcaserep-16-818" ref-type="bibr">10</xref>]. Differential diagnosis includes other vasculitides, such as polyarteritis nodosa, Churg-Strauss syndrome, Henoch-Sch&#xF6;nlein purpura, Wegener&#x2019;s granulomatosis, Takayasu arteritis, giant cell arteritis, disseminated intravascular coagulation, warfarin-induced skin necrosis, anti-phospholipid antibody syndrome, panniculitides, deep fungal infections, necrotizing fasciitis, and cholesterol embolization with superadded infection [<xref rid="b11-amjcaserep-16-818" ref-type="bibr">11</xref>].</p>
      <p>The pathogenesis of calciphylaxis in unclear. However, the proposed mechanism is that the presence of hyperparathyroidism, hyperphosphatemia, and high calcium-phosphate product in the uremic milieu down-regulates the inhibitors of vascular calcification. The ensuing vascular calcification leads to vasoconstriction, which ultimately leads to decreased distal perfusion and ischemic manifestations [<xref rid="b12-amjcaserep-16-818" ref-type="bibr">12</xref>]. Secondary hyperparathyroidism and disturbances in the metabolism of calcium and phosphate are thought to be the risk factors for calciphylaxis; therefore, it is more prevalent in patients with chronic renal failure on hemodialysis [<xref rid="b1-amjcaserep-16-818" ref-type="bibr">1</xref>]. There is often marked elevation in the serum calcium, phosphate, and intact parathormone levels; however, absence of these findings does not preclude the diagnosis [<xref rid="b9-amjcaserep-16-818" ref-type="bibr">9</xref>]. Radiographically, &#x201C;pipe stem&#x201D; calcification of the arteries and arterioles can be seen, as was seen in our patient (<xref ref-type="fig" rid="f1-amjcaserep-16-818">Figure 1C, 1D</xref>). Initially, patients with end-stage renal disease on hemodialysis present with violaceous skin lesions, but further manifestations depend upon the area of compromised blood supply. It ranges from central nervous system manifestations due to compromised blood supply to the brain parenchyma, to involvement of the visceral organs, which is rare.</p>
      <p>There have been very few reported cases of patients with gastrointestinal complications of calciphylaxis [<xref rid="b13-amjcaserep-16-818" ref-type="bibr">13</xref>]. Coates et al. described 16 patients with calciphylaxis; the cause of death in 2 of these patients was gastrointestinal hemorrhage [<xref rid="b14-amjcaserep-16-818" ref-type="bibr">14</xref>]. Gastrointestinal manifestations can include mucosal edema, diffuse ulcer formation, and bowel perforation arising from bowel infarction. Intestinal ischemia leading to gastrointestinal bleeding is a common presentation in these patients. Rarely, there can be an elevation of the liver function tests from involvement of the portal vein and hepatic arteries, leading to hepatic ischemia [<xref rid="b15-amjcaserep-16-818" ref-type="bibr">15</xref>]. Although the exact etiology of gastrointestinal bleeding in our patient could not be determined, the presence of extensive vascular calcification, multiple stenotic areas in the artery and its tributaries, and other overt manifestations of calciphylaxis led us to believe calciphylaxis was the cause of bleeding.</p>
      <p>We considered surgical resection of the ulcerated colon in our patient; however, it was not pursued further. The chances of healing of the resected margins were remote because of widespread calciphylaxis. Nieves et al. reported a case in which the colon was resected but the incisions did not heal and the patient eventually died of sepsis [<xref rid="b15-amjcaserep-16-818" ref-type="bibr">15</xref>].</p>
      <p>Management of gastrointestinal bleeding in patients with calciphylaxis can thus be done with the resection of the intestinal segment if the disease is not widespread and the long-term prognosis is good. Proton pump inhibitors can be used to manage the stress ulceration. Ablative therapies can be used if the area of bleeding is accessible and ablatable. Conservative management with blood transfusion as needed is usually pursued after exhaustion of definitive measures to stop the cause of bleeding.</p>
      <p>Supportive treatment is the mainstay of management of systemic calciphylaxis [<xref rid="b12-amjcaserep-16-818" ref-type="bibr">12</xref>]. Sodium thiosulphate has emerged as a novel treatment modality for the management of calciphylaxis. It binds to calcium and forms calcium thiosulphate, which can later be dialyzed. Some studies have shown that it increases the calcium solubility and inhibits the precipitation of calcium in tissues [<xref rid="b2-amjcaserep-16-818" ref-type="bibr">2</xref>,<xref rid="b6-amjcaserep-16-818" ref-type="bibr">6</xref>]. Although intravenous sodium thiosulphate has been the preferred route of treatment, a literature review revealed intralesional injections of sodium thiosulphate as an emerging new experimental treatment modality for cutaneous lesions [<xref rid="b6-amjcaserep-16-818" ref-type="bibr">6</xref>]. Patients who received sodium thiosulphate has been reported to produce a good response within a few weeks [<xref rid="b2-amjcaserep-16-818" ref-type="bibr">2</xref>,<xref rid="b6-amjcaserep-16-818" ref-type="bibr">6</xref>], but it did not help in our case. Pamidronate has also been used for managing calciphylaxis [<xref rid="b16-amjcaserep-16-818" ref-type="bibr">16</xref>&#x2013;<xref rid="b18-amjcaserep-16-818" ref-type="bibr">18</xref>]. Hyperbaric treatment has been tried in patients to assist with wound healing [<xref rid="b19-amjcaserep-16-818" ref-type="bibr">19</xref>], and parathyroidectomy has also been attempted [<xref rid="b9-amjcaserep-16-818" ref-type="bibr">9</xref>,<xref rid="b12-amjcaserep-16-818" ref-type="bibr">12</xref>]. Normalization of the abnormal calcium and phosphorus levels can also be helped by diet, binding agents, and low-calcium bath dialysate [<xref rid="b9-amjcaserep-16-818" ref-type="bibr">9</xref>].</p>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclusions</title>
      <p>Calciphylaxis is associated with a very high mortality that approaches 80% [<xref rid="b6-amjcaserep-16-818" ref-type="bibr">6</xref>,<xref rid="b20-amjcaserep-16-818" ref-type="bibr">20</xref>]. The diagnosis is usually made when the obvious skin lesions are present. However, visceral involvement is rare. It should be considered in the differential diagnosis in end-stage renal disease patients (on hemodialysis) presenting with abdominal pain or gastrointestinal bleeding.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References:</title>
      <ref id="b1-amjcaserep-16-818">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yerram</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Chaudhary</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Calcific uremic arteriolopathy in end stage renal disease: pathophysiology and management</article-title>
          <source>Ochsner J</source>
          <year>2014</year>
          <volume>14</volume>
          <issue>3</issue>
          <fpage>380</fpage>
          <lpage>85</lpage>
          <pub-id pub-id-type="pmid">25249804</pub-id>
        </element-citation>
      </ref>
      <ref id="b2-amjcaserep-16-818">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hayashi</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Calciphylaxis: diagnosis and clinical features</article-title>
          <source>Clin Exp Nephrol</source>
          <year>2013</year>
          <volume>17</volume>
          <issue>4</issue>
          <fpage>498</fpage>
          <lpage>503</lpage>
          <pub-id pub-id-type="pmid">23430392</pub-id>
        </element-citation>
      </ref>
      <ref id="b3-amjcaserep-16-818">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oliveira</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Frazao</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Calciphylaxis: from the disease to the diseased</article-title>
          <source>J Nephrol</source>
          <year>2015</year>
          <comment>[Epub ahead of print]</comment>
        </element-citation>
      </ref>
      <ref id="b4-amjcaserep-16-818">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brandenburg</surname>
              <given-names>VM</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Sohn</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Ketteler</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>[Calciphylaxis]</article-title>
          <source>Dtsch Med Wochenschr</source>
          <year>2015</year>
          <volume>140</volume>
          <issue>5</issue>
          <fpage>347</fpage>
          <lpage>51</lpage>
          <comment>[in German]</comment>
          <pub-id pub-id-type="pmid">25734678</pub-id>
        </element-citation>
      </ref>
      <ref id="b5-amjcaserep-16-818">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brown</surname>
              <given-names>DF</given-names>
            </name>
            <name>
              <surname>Denney</surname>
              <given-names>CF</given-names>
            </name>
            <name>
              <surname>Burns</surname>
              <given-names>DK</given-names>
            </name>
          </person-group>
          <article-title>Systemic calciphylaxis associated with massive gastrointestinal hemorrhage</article-title>
          <source>Arch Pathol Lab Med</source>
          <year>1998</year>
          <volume>122</volume>
          <issue>7</issue>
          <fpage>656</fpage>
          <lpage>59</lpage>
          <pub-id pub-id-type="pmid">9674549</pub-id>
        </element-citation>
      </ref>
      <ref id="b6-amjcaserep-16-818">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Strazzula</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Nigwekar</surname>
              <given-names>SU</given-names>
            </name>
            <name>
              <surname>Steele</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Intralesional sodium thiosulfate for the treatment of calciphylaxis</article-title>
          <source>JAMA Dermatol</source>
          <year>2013</year>
          <volume>149</volume>
          <issue>8</issue>
          <fpage>946</fpage>
          <lpage>49</lpage>
          <pub-id pub-id-type="pmid">23760631</pub-id>
        </element-citation>
      </ref>
      <ref id="b7-amjcaserep-16-818">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>KG</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Choong</surname>
              <given-names>LH</given-names>
            </name>
          </person-group>
          <article-title>Clinical features, therapy, and outcome of calciphylaxis in patients with end-stage renal disease on renal replacement therapy: Case series</article-title>
          <source>Hemodial Int</source>
          <year>2015</year>
          <comment>[Epub ahead of print]</comment>
        </element-citation>
      </ref>
      <ref id="b8-amjcaserep-16-818">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brandenburg</surname>
              <given-names>VM</given-names>
            </name>
            <name>
              <surname>Cozzolino</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mazzaferro</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Calcific uremic arteriolopathy: a call for action</article-title>
          <source>Semin Nephrol</source>
          <year>2014</year>
          <volume>34</volume>
          <issue>6</issue>
          <fpage>641</fpage>
          <lpage>47</lpage>
          <pub-id pub-id-type="pmid">25498382</pub-id>
        </element-citation>
      </ref>
      <ref id="b9-amjcaserep-16-818">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oh</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Eulau</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Tokugawa</surname>
              <given-names>DA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Five cases of calciphylaxis and a review of the literature</article-title>
          <source>J Am Acad Dermatol</source>
          <year>1999</year>
          <volume>40</volume>
          <issue>6 Pt 1</issue>
          <fpage>979</fpage>
          <lpage>87</lpage>
          <pub-id pub-id-type="pmid">10365930</pub-id>
        </element-citation>
      </ref>
      <ref id="b10-amjcaserep-16-818">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harb</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Watt</surname>
              <given-names>AW</given-names>
            </name>
            <name>
              <surname>Elston</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Harrington</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Calciphylaxis</article-title>
          <source>Eplasty</source>
          <year>2015</year>
          <volume>15</volume>
          <fpage>ic11</fpage>
          <pub-id pub-id-type="pmid">25834692</pub-id>
        </element-citation>
      </ref>
      <ref id="b11-amjcaserep-16-818">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miloslavsky</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Stone</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Unizony</surname>
              <given-names>SH</given-names>
            </name>
          </person-group>
          <article-title>Challenging mimickers of primary systemic vasculitis</article-title>
          <source>Rheum Dis Clin North Am</source>
          <year>2015</year>
          <volume>41</volume>
          <issue>1</issue>
          <fpage>141</fpage>
          <lpage>60</lpage>
          <fpage>ix</fpage>
          <pub-id pub-id-type="pmid">25399945</pub-id>
        </element-citation>
      </ref>
      <ref id="b12-amjcaserep-16-818">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tamayo-Isla</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Cuba de la Cruz</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Calciphylaxis in end-stage renal disease prior to dialytic treatment: a case report and literature review</article-title>
          <source>Int J Nephrol Renovasc Dis</source>
          <year>2015</year>
          <volume>8</volume>
          <fpage>13</fpage>
          <lpage>18</lpage>
          <pub-id pub-id-type="pmid">25709494</pub-id>
        </element-citation>
      </ref>
      <ref id="b13-amjcaserep-16-818">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tamura</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hiroshige</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Osajima</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A dialysis patient with systemic calciphylaxis exhibiting rapidly progressive visceral ischemia and acral gangrene</article-title>
          <source>Intern Med</source>
          <year>1995</year>
          <volume>34</volume>
          <issue>9</issue>
          <fpage>908</fpage>
          <lpage>12</lpage>
          <pub-id pub-id-type="pmid">8580568</pub-id>
        </element-citation>
      </ref>
      <ref id="b14-amjcaserep-16-818">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Coates</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kirkland</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Dymock</surname>
              <given-names>RB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cutaneous necrosis from calcific uremic arteriolopathy</article-title>
          <source>Am J Kidney Dis</source>
          <year>1998</year>
          <volume>32</volume>
          <issue>3</issue>
          <fpage>384</fpage>
          <lpage>91</lpage>
          <pub-id pub-id-type="pmid">9740153</pub-id>
        </element-citation>
      </ref>
      <ref id="b15-amjcaserep-16-818">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rivera-Nieves</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bamias</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Alfert</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Intestinal ischemia and peripheral gangrene in a patient with chronic renal failure</article-title>
          <source>Gastroenterology</source>
          <year>2002</year>
          <volume>122</volume>
          <issue>2</issue>
          <fpage>495</fpage>
          <lpage>99</lpage>
          <pub-id pub-id-type="pmid">11832463</pub-id>
        </element-citation>
      </ref>
      <ref id="b16-amjcaserep-16-818">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hooman</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Naghshi-Zadiyan</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Successful treatment of calciphylaxis with pamidronate</article-title>
          <source>Iran J Kidney Dis</source>
          <year>2015</year>
          <volume>9</volume>
          <issue>1</issue>
          <fpage>67</fpage>
          <lpage>70</lpage>
          <pub-id pub-id-type="pmid">25599740</pub-id>
        </element-citation>
      </ref>
      <ref id="b17-amjcaserep-16-818">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schliep</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Schuler</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Kiesewetter</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Successful treatment of calciphylaxis with pamidronate</article-title>
          <source>Eur J Dermatol</source>
          <year>2008</year>
          <volume>18</volume>
          <issue>5</issue>
          <fpage>554</fpage>
          <lpage>56</lpage>
          <pub-id pub-id-type="pmid">18693159</pub-id>
        </element-citation>
      </ref>
      <ref id="b18-amjcaserep-16-818">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>da Costa</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>da Costa</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Gomes</surname>
              <given-names>MM</given-names>
            </name>
          </person-group>
          <article-title>Pamidronate as a treatment option in calciphylaxis</article-title>
          <source>J Eur Acad Dermatol Venereol</source>
          <year>2008</year>
          <volume>22</volume>
          <issue>9</issue>
          <fpage>1128</fpage>
          <lpage>30</lpage>
          <pub-id pub-id-type="pmid">18070019</pub-id>
        </element-citation>
      </ref>
      <ref id="b19-amjcaserep-16-818">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>An</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Devaney</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Ooi</surname>
              <given-names>KY</given-names>
            </name>
            <name>
              <surname>Ford</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Hyperbaric oxygen in the treatment of calciphylaxis: A case series and literature review</article-title>
          <source>Nephrology (Carlton)</source>
          <year>2015</year>
          <volume>20</volume>
          <issue>7</issue>
          <fpage>444</fpage>
          <lpage>50</lpage>
          <pub-id pub-id-type="pmid">25707425</pub-id>
        </element-citation>
      </ref>
      <ref id="b20-amjcaserep-16-818">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nigwekar</surname>
              <given-names>SU</given-names>
            </name>
            <name>
              <surname>Solid</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Ankers</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Quantifying a rare disease in administrative data: the example of calciphylaxis</article-title>
          <source>J Gen Intern Med</source>
          <year>2014</year>
          <volume>29</volume>
          <issue>Suppl.3</issue>
          <fpage>S724</fpage>
          <lpage>31</lpage>
          <pub-id pub-id-type="pmid">25029979</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="f1-amjcaserep-16-818" position="float">
      <label>Figure 1.</label>
      <caption>
        <p>(<bold>A, B</bold>) Black necrotic eschar on bilateral lower extremities. (<bold>C, D</bold>) Radiograph of legs showed extensive calcification of the lower extremity arteries.</p>
      </caption>
      <graphic xlink:href="amjcaserep-16-818-g001"/>
    </fig>
    <fig id="f2-amjcaserep-16-818" position="float">
      <label>Figure 2.</label>
      <caption>
        <p>(<bold>A, B</bold>) CT scan of the abdomen demonstrating severe circumferential calcification of the abdominal aorta, celiac artery, superior and inferior mesenteric arteries and their branches (stars highlight areas of extensive calcification along the visceral organs, arrow heads and arrows indicate extensive calcification of all the arteries within the abdomen).</p>
      </caption>
      <graphic xlink:href="amjcaserep-16-818-g002"/>
    </fig>
    <fig id="f3-amjcaserep-16-818" position="float">
      <label>Figure 3.</label>
      <caption>
        <p>Colonoscopy demonstrating severe rectal ulceration extending up to the muscularis mucosa with rectal necrosis.</p>
      </caption>
      <graphic xlink:href="amjcaserep-16-818-g003"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
